PharmAust (ASX: PAA) ready to trial monepantel on humans to fight motor neurone disease (w/ Dr Roger Aston)

Small Caps - A podcast by Small Caps

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

PharmAust (ASX: PAA) executive chairman and CEO Dr Roger Aston joins Small Caps to discuss the latest news in relation to its lead drug...